GENOTROPIN PEN Trademark

Trademark Overview

On Friday, August 4, 1995, a trademark application was filed for GENOTROPIN PEN with the United States Patent and Trademark Office. The USPTO has given the GENOTROPIN PEN trademark a serial number of 74710962. The federal status of this trademark filing is REGISTERED AND RENEWED as of Tuesday, June 7, 2016. This trademark is owned by PHARMACIA AB. The GENOTROPIN PEN trademark is filed in the Medical Instrument Products category with the following description:

medical devices for injecting pharmaceuticals
genotropin pen

General Information

Serial Number74710962
Word MarkGENOTROPIN PEN
Filing DateFriday, August 4, 1995
Status800 - REGISTERED AND RENEWED
Status DateTuesday, June 7, 2016
Registration Number2033472
Registration DateTuesday, January 28, 1997
Mark Drawing1 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 5, 1996

Trademark Statements

NOT AVAILABLE"PEN"
Goods and Servicesmedical devices for injecting pharmaceuticals

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, October 27, 2004
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePFIZER HEALTH AB
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressSollentuna SE191 90
SE
Party NamePHARMACIA AB
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSE-112 87 Stockholm
SE
Party NamePHARMACIA AB
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressS-171 97 Stockholm
SE
Party NamePHARMACIA AB
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressS-171 97 Stockholm
SE

Trademark Events

Event DateEvent Description
Tuesday, January 2, 1996ASSIGNED TO EXAMINER
Thursday, January 25, 1996NON-FINAL ACTION MAILED
Wednesday, June 19, 1996CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 19, 1996APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 4, 1996NOTICE OF PUBLICATION
Tuesday, November 5, 1996PUBLISHED FOR OPPOSITION
Tuesday, January 28, 1997REGISTERED-PRINCIPAL REGISTER
Wednesday, January 22, 2003PAPER RECEIVED
Wednesday, January 22, 2003REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Tuesday, April 22, 2003POST REGISTRATION ACTION MAILED - SEC. 8 & 15
Wednesday, June 25, 2003FAX RECEIVED
Wednesday, April 14, 2004CANCELLED SEC. 8 (6-YR)
Thursday, September 9, 2004PAPER RECEIVED
Tuesday, September 28, 2004TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, October 27, 2004REINSTATED
Wednesday, October 27, 2004REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, November 16, 2004TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, December 6, 2006TEAS SECTION 8 & 9 RECEIVED
Wednesday, December 6, 2006REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
Friday, December 29, 2006CASE FILE IN TICRS
Friday, February 9, 2007ASSIGNED TO PARALEGAL
Friday, February 9, 2007REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Friday, February 9, 2007REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Thursday, December 10, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 10, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 28, 2016COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Monday, March 21, 2016TEAS SECTION 8 & 9 RECEIVED
Tuesday, June 7, 2016CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, June 7, 2016REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Tuesday, June 7, 2016REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Tuesday, June 7, 2016NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Wednesday, January 28, 2026COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, January 30, 2026TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, January 30, 2026ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, January 30, 2026TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

genotropin pharmaceuticals injecting devices medical